These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9386988)

  • 1. Detection of vascular endothelial growth factor (VEGF) protein in vascular and non-vascular cells of the normal and oxygen-injured rat retina.
    Robbins SG; Conaway JR; Ford BL; Roberto KA; Penn JS
    Growth Factors; 1997; 14(4):229-41. PubMed ID: 9386988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors flt-1 and flk-1 in the oxygen-injured rat retina.
    Robbins SG; Rajaratnam VS; Penn JS
    Growth Factors; 1998; 16(1):1-9. PubMed ID: 9777366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate.
    Tolentino MJ; McLeod DS; Taomoto M; Otsuji T; Adamis AP; Lutty GA
    Am J Ophthalmol; 2002 Mar; 133(3):373-85. PubMed ID: 11860975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of retinal neovascularization in a rat model of oxygen fluctuations-induced retinopathy].
    Liu X; Wang W; Wang AR; Ning Q; Luo XP
    Zhonghua Er Ke Za Zhi; 2007 Jan; 45(1):7-13. PubMed ID: 17349140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat.
    Dorey CK; Aouididi S; Reynaud X; Dvorak HF; Brown LF
    Arch Ophthalmol; 1996 Oct; 114(10):1210-7. PubMed ID: 8859080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity.
    Geisen P; Peterson LJ; Martiniuk D; Uppal A; Saito Y; Hartnett ME
    Mol Vis; 2008 Feb; 14():345-57. PubMed ID: 18334951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGFbeta) in experimental autoimmune uveoretinitis: upregulation of VEGF without neovascularization.
    Vinores SA; Chan CC; Vinores MA; Matteson DM; Chen YS; Klein DA; Shi A; Ozaki H; Campochiaro PA
    J Neuroimmunol; 1998 Aug; 89(1-2):43-50. PubMed ID: 9726824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy.
    Donahue ML; Phelps DL; Watkins RH; LoMonaco MB; Horowitz S
    Curr Eye Res; 1996 Feb; 15(2):175-84. PubMed ID: 8670726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in sickle cell retina and choroid.
    Kim SY; Mocanu C; Mcleod DS; Bhutto IA; Merges C; Eid M; Tong P; Lutty GA
    Exp Eye Res; 2003 Oct; 77(4):433-45. PubMed ID: 12957143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
    Pierce EA; Foley ED; Smith LE
    Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
    McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
    Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
    Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
    Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA
    Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cell biology of intraocular vascular diseases].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates.
    Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
    Lab Invest; 1996 Jan; 74(1):68-77. PubMed ID: 8569199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
    Pierce EA; Avery RL; Foley ED; Aiello LP; Smith LE
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):905-9. PubMed ID: 7846076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline inhibition of vasculogenesis in the neonatal rat retina.
    Hasebe Y; Thomson LR; Dorey CK
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2774-8. PubMed ID: 10937597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hypoxia during normal retinal vessel development and in experimental retinopathy of prematurity.
    Zhang W; Ito Y; Berlin E; Roberts R; Berkowitz BA
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3119-23. PubMed ID: 12824260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases.
    Pe'er J; Shweiki D; Itin A; Hemo I; Gnessin H; Keshet E
    Lab Invest; 1995 Jun; 72(6):638-45. PubMed ID: 7540233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.